CXCL8 and metabolic dysfunction-associated steatohepatitis: To determine the dynamic changes in IL8 expression during NASH progression, we analyzed publicly available RNA sequencing (RNA-seq) data from patients with NAFLD (GSE135251 and GSE167523), which have been recently published with the information for hepatic gene expression compared between individuals with different stages of NASH as well as fatty liver [27,28].